Since DCIS-like lesions secondary to estrogen treatment in Cav-1 KO mice showed increased levels of phosphorylated STAT5a (Y694) as shown in Figure 1, we questioned whether this was a bystander or functional effect of this transcription factor. This evidence concerns the gene STAT5A and ductal breast carcinoma in situ.